2003

Arendt G, Haslinger BA. Rationale Diagnostik bei neurologischen Manifestationen der HIV-Infektion in der HAART-Ära. Münchener Medizinische Wochenschrift 2003; 145: 66-69.

Arendt G, Haslinger BA. Psychiatrische Komplikationen bei der HIV-Infektion. Münchener Medizinische Wochenschrift 2003; 145: 70-72.

Arendt G, Giesen, H-Jv and the HIV-Women´s Forum Northrhine-Westphalia. HIV-1-positive female migrants in Northrhine-Westphalia - relevant, but unfocussed problem? European Journal of Medical Research 2003; 8: 137-141.

Arendt G, Haslinger BA, Köller H, Giesen HJv, Antke C, Wenserski F, Wittsack HJ. Von der strukturellen zur funktionellen und molekularen Bildgebung - Die Zukunft der Pathogeneseforschung bei Neuro-AIDS? Medical Review 2003; 6: 10-11.

Auer-Grumbach M, De Jonghe P, Verhoeven K, Timmerman V, Wagner K, HartungHP, Nicholson GA. Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review. Archives of Neurology 2003; 60: 329-334.

Bandmann O, Goertz M, Zschocke J, Deuschl G, Jost W, Hefter H, Muller U, Zofel P, Hoffmann G, Oertel W. The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 2003; 60: 700-702.

Barkhof F, Rocca M, Francis G, Van Waesberghe JH, Uitdehaag BM, Hommes OR, Hartung HP, Durelli L, Edan G, Fernandez O, Seeldrayers P, Sorensen P, Margrie S, Rovaris M, Comi G and Filippi M. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Annals of Neurology 2003; 53: 718-724.

Beaujean D, Rosenbaum C, Müller HW, Willemsen JJ, Lenders J, Bornstein SR. Combinatorial code of growth factors and neuropeptides define neuroendocrine differentiation in PC12 cells. Experimental Neurology 2003; 184: 348-358.

Bosse F, Hasse B, Pippirs U, Greiner-Petter R, Müller HW. Proteolipid plasmolipin: localization in polarized cells, regulated expression and lipid raft association in CNS and PNS myelin. Journal of Neurochemistry 2003; 86: 508-518.

Bütefisch CM, Netz J, Schicks W, Seitz RJ, Hömberg V. Remote changes in cortical excitability after stroke. Brain 2003; 126: 470-481.

Cepok S, Zhou D, Vogel F, Rosche B, Grummel V, Sommer N, Hemmer B. Immune dynamics during acute neuroborreliosis - recruitment of plasma cells and activation of monocyte derived cytokines. Archives of Neurology 2003; 60: 849-855.

Cincotta M, Borgheresi A, Balestrieri F, Zaccara G, Kessler KR, Schnitzler A, Classen J, Benecke R. Reduced inhibition within primary motor cortex in patients with poststroke focal motor seizures. Neurology 2003; 60: 527-528.

Dihne M, Bernreuther C, Sibbe M, Paulus W, Schachner M. A new role for the cell adhesion molecule L1 in neural precursor cell proliferation, differentiation, and transmitter-specific subtype generation. Journal of Neuroscience 2003; 23: 6638-6650.

Edan G, Morrissey SP, Hartung HP. Use of mitoxantrone to treat multiple sclerosis. In: Cohen JA, Rudick RA (eds) Multiple Sclerosis Therapeutics. 2nd ed. Martin Dunitz Ltd, Taylor & Francis Group, London, 2003; 403-426.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP Fazekas F. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele. Archives of Neurology 2003; 60: 65-70.

Giesen HJv, Niehues T, Reumel J, Haslinger B, Ndagijimana J, Arendt G. Delayed motor learning and psychomotor slowing in HIV-infected children. Neuropediatrics 2003; 34: 177-181.

Giesen HJv, Koeller H, de Nocker D, Haslinger BA, Arendt G. Long-term safety and efficacy of NNRTI within the central nervous system. HIV Clinical Trials 2003; 4: 382-390.

Giesen HJv, Weiß P, Arendt G, Hefter H. Potential c-fiber damage in Wilson´s disease. Acta Neurologica Scandinavica 2003; 108: 257-261.

Görtz P, Köller H, Schwahn B, Wendel U, Siebler M. Disturbance of cultured rat neuronal network activity depends on concentration and ratio of leucine and a-ketoisocaproate- implication for acute encephalopathy of Maple Syrup Urine Disease. Pediatric Research2003; 53: 320-324.

Gross J, Timmermann L, Kujala J, Salmelin R, Schnitzler A. Properties of MEG tomographic maps obtained with spatial filtering. Neuroimage 2003; 19: 1329-1336.

Hartung HP, Kieseier BC. Autoimmunity in the nervous system. In: Noseworthy J (ed.) Neurological Therapeutics: Principles and Practice. Martin Dunitz, London, 2003; 1094-1106.

Hartung HP, Kieseier BC. Experimental autoimmune encephalomyelitis. In: Wood P (ed.) Neuroimmunology - Mechanisms and Management. Humana Press, Totowa NJ, 2003; 345-357.

Hartung HP, Kieseier BC. Neuroimmunology of Guillain-Barré syndrome. In: Aminoff M, Daroff R (eds.) Encyclopedia of the Neurological Sciences. Academic Press, San Diego, 2003.

Hartung HP, Kieseier BC. Intravenous immunoglobulins -mechanisms of action. In: Jolles S (ed.) Use of intravenous immunoglobulin in clinical dermatology Martin Dunitz, London, 2003; 1-20.

Hartung HP, Kieseier BC, Archelos JJ. Neuromuskuläre Störungen beim Intensivpatienten. In: Burchardi H, Larsen R, Schuster HP, Suter PN (eds.) Intensivmedizin9. Auflage, Georg Thieme Verlag, Stuttgart, 2003; 737-746.

Hemmer B, Kieseier B, Cepok S, Hartung HP. New immuno-pathologic insights into multiple sclerosis. Current Neurology Neuroscience Reports 2003; 3: 246-255.

Homann CN, Quehenberger F, Petrovic K, Hartung HP, Ruzicka E, Homann B, Suppan K, Wenzel K, Ivanic G and Ott E. Influence of age, gender, education and dexterity on upper limb motor performance in Parkinsonian patients and healthy controls. Journal of Neural Transmission 2003; 110: 885-897.

Hu W, Mathey E, Hartung HP, Kieseier BC. Cyclooxygenases and prostaglandins in inflammatory deymelination of the peripheral nerve. Neurology 2003; 61: 1774-1779.

Huber R, Müller BT, Seitz RJ, Siebler M, Mödder U, Sandmann W. Carotid surgery in acute symptomatic patients. European Journal of Vascular and Endovascular Surgery 2003; 25: 60-67.

Ignatov A, Lintzel J, Hermans-Borgmeyer I, Kreienkamp HJ, Thomsen S, Joost P, Methner A, Schaller HC. Role of GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development. Journal of Neuroscience 2003; 23: 907-914.

Jacobsen M, ZhouD, Cepok S, Happel M, Stei S, Wilske B, Sommer N, Hemmer B. Activated CD8+ T cells accumulate in the cerebrospinal fluid during the early phase of neuroborreliosis. Journal of Infectious Diseases 2003;187: 963-973.

Jander S. Disorders of myelin in the central and peripheral nervous systems. Lancet Neurology 2003; 2: 258.

Junghans U, Siebler M. Cerebral Microembolism is blocked by Tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation 2003; 107: 2717-2721.

Kappos L, Polman C, Thompson AJ, Duda P, Clanet M, Comi G, Hartung HP, Montalban X. Towards a European network for multiple sclerosis trials (ENMST). Multiple Sclerosis 2003; 9: 627-629.

Kastenbauer S, Koedel U, Wick M, Kieseier BC, Hartung HP, Pfister HW. Cerebrospinal and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. Journal of Neuroimmunology 2003; 137: 210-217.

Kessler KR, Wunderlich G, Hefter H, Seitz RJ. Secondary progressive chronic manganism associated with markedly decreased striatal D2 receptor density. Movement Disorders 2003; 18: 217-218.

Kieseier BC, Gold R,Hartung HP. Mitoxantron zur Therapie der Multiplen Sklerose. Nervenarzt2003; 74: 906-910.

Kieseier BC, Hartung HP. Current disease-modifying therapies in multiple sclerosis.Seminars in Neurology200323: 133-146 Erratum in: 23: 343-344.

Kieseier BC, Hartung HP. Multiple paradigm shifts in multiple sclerosisCurrent Opinion in Neurology2003; 16: 247-252.

Kieseier BC, Hartung HP. Neuroimmunology, overview. In: Aminoff M, Daroff R (eds.) Encyclopedia of the Neurological Sciences. Academic Press, San Diego, 2003; 489-492.

Kieseier BC, Hartung HP. Peripheral nervous system, immunology of. In: Aminoff M, Daroff R (eds.) Encyclopedia of the Neurological Sciences. Academic Press, San Diego, 2003; 846-849.

Kieseier BC, Hartung HP. Therapeutic strategies in the Guillain-Barré syndrome. Seminars in Neurology 2003; 23: 159-168.

Kieseier BC, Pischel H, Neuen-Jacob E, Tourtellotte WW, Hartung HP. ADAM-10 and ADAM-17 in the inflamed human CNS. Glia 2003; 42: 398-405.

Köller H, Kieseier BC, Jander S, Hartung HP. Chronisch inflammatorische demyelinisierende Polyneuropathie. Nervenarzt 2003; 74: 320-333.

Köller HKieseier BC, Jander S, Hartung HP. Akute und chronisch entzündliche Neuropathien - das Guillain-Barré Syndrom und die CIDP: I Diagnostik. Deutsche Medizinische Wochenschrift 2003; 128: 1357-1360.

Köller H, Kieseier BC, Jander S, Hartung HP. Akute und chronisch entzündliche Neuropathien - das Guillain-Barré Syndrom und die CIDP: II. Therapie. Deutsche Medizinische Wochenschrift 2003; 128: 1405-1407.

Köller H,Kornischka J, Neuen-Jacob E, Saleh A, Giesen HJv, Schmiedel J, Reichmann H, Hartung H-P. Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome. Journal of Neurology 2003; 250: 1501-1502.

Küry P, Köller H, Hamacher M, Cornely C, Hasse B, Müller HW. Cyclic AMP and tumor necrosis factor-α regulate CXCR4 gene expression in Schwann cells. Molecular Cellular Neuroscience2003;24: 1-9.

Lehmann HC, Hartung HP, Kieseier BC. The prefaces of Charcot: Leitmotifs of an international career. Neurology 2003; 61: 1163.

Lewerenz J, Letz J, Methner A. Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress. Journal of Neurochemistry 2003; 87: 522-531.

Lewerenz J, Leypoldt F, Methner A. Degenerate suppression PCR identifies the beta2-adrenergic receptor as upregulated by neuronal differentiation. Gene Expression 2003; 11: 105-116.

Lewerenz J, Gocht A, Hoeger P, von den Driesch P, Eckert B, Lamszus K, Stuerenburg HJ, Methner A. Multiple vascular abnormalities and a paradoxical combination of vitamin B12 deficiency and thrombocytosis in a case with POEMS syndrome. Journal of Neurology2003; 250: 1488-1491.

Lewerenz J, Thomsen S., Steinbeck JA, Methner A. Short-term serum supplementation improves glucose-oxygen deprivation in primary cortical cultures grown under serum-free conditions. Methods in Cell Science 2003; 25: 227-236.

Loos M, Dihne M, Block F. Tumor necrosis factor-alpha expression in areas of remote degeneration following middle cerebral artery occlusion of the rat. Neuroscience2003;122: 373-80.

Neuhaus O, Archelos JJ, Hartung HP. Statins in multiple sclerosis - a new therapeutic option? Multiple Sclerosis 2003; 9: 429-430.

Neuhaus O, Kieseier BC, Hartung HP. New concepts in pathogenesis and therapy in multiple sclerosis. BIOforum Europe 2003; 7: 329-331.

Neuhaus O, Kieseier BC, Archelos JJ, Hartung HP. Oxidative toxicity and glutamate excitotoxicity in multiple sclerosis. Trends in Pharmacological Sciences 2003; 24: 564-565.

Neuhaus O, Wiendl H, Kieseier BC, Archelos JJ, Hartung HP. Cholesterinsenker - eine neue Therapieoption bei Multipler Sklerose? Statine als Immunmodulatoren. Nervenarzt 2003; 74: 704-707.

Neuhaus O, Archelos JJ, Hartung HP. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection. Trends in Pharmacological Sciences 2003; 24: 563-564.

Noseworthy J, Hartung HP. Multiple sclerosis and related conditions. In: Noseworthy J (ed.) Neurological Therapeutics. Principles and Practice. Martin Dunitz, London, 2003; 1107-1134.

Otto F, Görtz P, Fleischer W, Siebler M. Cryopreserved rat cortical cells develop functional neuronal networks on microelectrode arrays. Journal of Neuroscience Methods 2003; 128: 173-181.

Paul R, Koedel U, Winkler F,Kieseier BC, Fontana A, Kopf M,Hartung HP, Pfister HW. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 2003; 126: 1873-1882.

Petereit HF, Pukrop R, Fazekas F, Bamborschke SU, Ropele S, Kolmel HW, Merkelbach S, Japp G, Jongen PJ, Hartung HP, Hommes OR. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. Journal of the Neurological Sciences 2003; 206: 209-214.

Ploner M, Schnitzler A. Wernicke´s Encephalopathy [clinical picture]. Lancet 2003; 361: 1000.

Ploner M, Schnitzler A. Kortikale Repräsentation von Schmerz. Neuroforum 2003; 3: 72-78.

Pollok B, Muller K, Aschersleben G, Schmitz F, Schnitzler A, Prinz W. Cortical activations associated with auditorily paced finger tapping. Neuroreport 2003; 14: 247-250.

Quasthoff S, Pojer C, Mori A, Hofer D, Liebermann P, Kieseier BC, Schreibmaier W. No blocking effect of the pentapeptide QYNAD on Na channel subtypes of isolated rat sural nerve. Neuroscience Letters2003352: 93-96.

Quattrini A, Previtali SC, Kieseier BC, Kiefer R, Comi G, Hartung HP. Autoimmunity in the peripheral nervous system. Critical Reviews in Neurobiology 2003; 15: 1-39.

Rosche B, Hemmer B. Experimentelle Therapien bei neuroimmunologischen Erkrankungen. In: Zettl U, Mix E (eds.) Bildgebung in der Neuroimmunologie Thieme Verlag, Stuttgart, 2003; 118-133.

Rosche B, Kieseier B, Hartung HP, Hemmer B. Neue immunpathogenetische Konzepte bei der Multiplen Sklerose. Nervenarzt 2003; 74: 654-663.

Schlosshauer B, Müller E, Schröder B, Müller HW. Rat Schwann cells in bioresorbable nerve guides to accelerate axonal regeneration. Brain Research 2003; 963: 321-326.

Schnitzler A, Pollok B, Schnitzler I. The role of somatosensory cortex in recognition of emotion. Sprache, Stimme, Gehör 2003; 27: 66-70.

Schroeter M, Küry P, Jander S. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Molecular Brain Research 2003; 117: 1-7.

Schroeter M, Stoll G, Weissert R, Hartung HP, Lassmann H, Jander S. CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction. American Journal of Pathology 2003; 163: 1517-1524.

Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke 2003; 34: 1932-1935.

Sporer B, Kastenbauer St, Koedel U, Arendt G, Pfister HW. Increased intrathecal release of soluble fractalkine in HIV-infected patients. AIDS Research Human Retroviruses 2003; 19: 111-116.

Steck A, Hartung HP, Kieseier BC. Demyelinisierende Erkrankungen. Steinkopff-Verlag, Darmstadt, 2003.

Stefanova I, Hemmer B, Vergelli M, Martin R, Germain RN. TCR desensitization by SHP-1 contributes to antagonist-mediated inhibition and temporally regulates agonist signaling. Nature Immunology 2003; 4: 248-254.

Tackenberg B, Nitschke M, Jacobsen M, Willcox N, Ziegler A, Nessler S, Rissling I, Schumm F, Oertel WH, Hemmer B, Sommer N. Association analysis of variant CD45 expression with myasthenia gravis. Impact on multiple sclerosis. Autoimmunity 2003; 36: 117-121.

Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A. Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling. Neurology2003; 61: 689-692.

Timmermann L, Gross J, Dirks M, Volkmann J, Freund HJ, Schnitzler A. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003; 126: 199-212.

Timmermann L, Gross J, Kircheis G, Butz M, Häussinger D, Schnitzler A. Cortical origin of mini-asterixis in hepatic encephalopathy. In: Jones EA, Meijer AJ, Chamuleau RAFM (eds.) Encephalopathy and Nitrogen Metabolism in Liver Failure. Kluwer Academic Publishers, Dordsrecht, the Netherlands, 2003; 105-112.

Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, FitzPatrick D, Schmedding E, De Vriendt E, Jacobs A, Van Gerwen V, Wagner K, Hartung HP and Timmerman V. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. American Journal of Human Genetics 2003; 72: 722-727.

Wenserski F, Giesen HJv, Wittsack HJ, Aulich A, Arendt G. Human immunodeficiency virus 1-associated minor motor disorders: perfusion-weighted MR imaging and H-MR-spectroscopy. Radiology 2003; 228: 185-192.

Wiendl H, Kieseier BC. Disease modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies. Expert Opinion on Investigational Drugs 2003; 12: 689-712.

Wiendl H, Lehmann HC, Hohlfeld R, Hartung HP, Kieseier BC. Immunmodulierende Therapiestrategien bei der Multiplen Sklerose: Übersicht und aktueller Stand klinischer Studien. Aktuelle Neurologie2003; 30: 433-441.

MediathekInformation und Wissen
LageplanSo finden Sie uns